12- NCT043
49,631 A Clinical Trial to
Determine the Safety
and Efficacy of Hope
Biosciences
Autologous
Mesenchymal Stem
Cell Therapy (HBadMSCs)
to Provide
Protection Against
COVID19 II Enrolling by
invitation 56 AD-MSCs DOS: May 2020
DOC: December 2020 Both Child, Adult,
Older
Adult United States